Zoledronic Acid
Product manufactured by Heritage Pharmaceuticals Inc. D/b/a Avet Pharmaceuticals Inc.
Indications and Purposes
| 1 Indications And Usage Zoledronic Acid Injection Is A Bisphosphonate Indicated For The Treatment Of: Hypercalcemia Of Malignancy. (1.1) Patients With Multiple Myeloma And Patients With Documented Bone Metastases From Solid Tumors, In Conjunction With Standard Antineoplastic Therapy. Prostate Cancer Should Have Progressed After Treatment With At Least One Hormonal Therapy. (1.2) Important Limitation Of Use: The Safety And Efficacy Of Zoledronic Acid Injection Has Not Been Established For Use In Hyperparathyroidism Or Nontumor-Related Hypercalcemia. (1.3) 1.1 Hypercalcemia Of Malignancy Zoledronic Acid Injection Is Indicated For The Treatment Of Hypercalcemia Of Malignancy Defined As An Albumin-Corrected Calcium (Cca) Of Greater Than Or Equal To 12 Mg/dl [3.0 Mmol/l] Using The Formula: Cca In Mg/dl=ca In Mg/dl + 0.8 ( 4.0 G/dl - Patient Albumin [G/dl]). 1.2 Multiple Myeloma And Bone Metastases Of Solid Tumors Zoledronic Acid Injection Is Indicated For The Treatment Of Patients With Multiple Myeloma And Patients With Documented Bone Metastases From Solid Tumors, In Conjunction With Standard Antineoplastic Therapy. Prostate Cancer Should Have Progressed After Treatment With At Least One Hormonal Therapy. 1.3 Important Limitation Of Use The Safety And Efficacy Of Zoledronic Acid Injection In The Treatment Of Hypercalcemia Associated With Hyperparathyroidism Or With Other Nontumor-Related Conditions Have Not Been Established. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Zoledronic Acid |
|
ZINC4501392 |